EKF Diagnostics Holdings Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Public

  • Employees
  • 301

Employees

  • Stock Symbol
  • EKF

Stock Symbol

  • Investments
  • 12

  • Share Price
  • $0.31
  • (As of Wednesday Closing)

EKF Diagnostics Holdings General Information

Description

EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.

Contact Information

Formerly Known As
EKF Industrie-Elektronik
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Avon House
  • 19 Stanwell Road, Penarth
  • Cardiff CF64 2EZ
  • Wales, United Kingdom
+44 029
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Stock Exchange
LON
Corporate Office
  • Avon House
  • 19 Stanwell Road, Penarth
  • Cardiff CF64 2EZ
  • Wales, United Kingdom
+44 029

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EKF Diagnostics Holdings Stock Performance

As of 18-Nov-2026, EKF Diagnostics Holdings’s stock price is $0.31. Its current market cap is $132M with 428M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.31 $0.31 $0.29 - $0.39 $132M 428M 373K

EKF Diagnostics Holdings Financials Summary

As of 30-Jun-2026, EKF Diagnostics Holdings has a trailing 12-month revenue of $68.9M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 139,284 137,576 147,181 173,396
Revenue 68,907 67,921 64,134 65,398
EBITDA 16,377 16,299 14,035 9,389
Net Income 3,352 2,795 7,976 2,924
Total Assets 109,135 109,258 102,572 102,994
Total Debt 1,950 1,865 1,654 5,222
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EKF Diagnostics Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EKF Diagnostics Holdings‘s full profile, request access.

Request a free trial

EKF Diagnostics Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitr
Diagnostic Equipment
Cardiff, United Kingdom
301 As of 2025

Bethlehem, PA
 

Hercules, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EKF Diagnostics Holdings Competitors (5)

One of EKF Diagnostics Holdings’s 5 competitors is Orasure Technologies, a Corporate Backed or Acquired company based in Bethlehem, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orasure Technologies Corporate Backed or Acquired Bethlehem, PA
Bio-Rad Laboratories Corporation Hercules, CA
Abbott India Corporation Mumbai, India
GE HealthCare Technologies Corporation Chicago, IL
Guerbet Group Corporation Villepinte, France
You’re viewing 5 of 5 competitors. Get the full list »

EKF Diagnostics Holdings Patents

EKF Diagnostics Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4500166-A1 Method and sensor for determining a plasma-related analyte concentration in whole blood Pending 28-Mar-2022
US-20250020612-A1 Method and sensor for determining a plasma-related analyte concentration in whole blood Pending 28-Mar-2022
DE-102008039810-B3 Disposable microcuvette for determination of hemoglobin content in whole blood Inactive 25-Aug-2008
ES-2537967-T3 Disposable microcuvette to determine the hemoglobin content of whole blood Active 25-Aug-2008
EP-2159565-A1 One-off micro-bulb for determining the haemoglobin content in whole blood Active 25-Aug-2008 G01N21/03
To view EKF Diagnostics Holdings’s complete patent history, request access »

EKF Diagnostics Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EKF Diagnostics Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EKF Diagnostics Holdings‘s full profile, request access.

Request a free trial

EKF Diagnostics Holdings Investments & Acquisitions (12)

EKF Diagnostics Holdings’s most recent deal was a Corporate Asset Purchase with Beep Insights (Technology Assets). The deal was made on 13-Apr-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Beep Insights (Technology Assets) 13-Apr-2026 Corporate Asset Purchase Buildings and Property
Verici Dx 07-Mar-2022 PIPE Laboratory Services (Healthcare)
Advanced Diagnostic Laboratory 12-Oct-2021 Merger/Acquisition Laboratory Services (Healthcare)
Trellus (Other Healthcare Services) 20-Aug-2020 Seed Round Other Healthcare Services
Renalytix 26-Apr-2019 PIPE Decision/Risk Analysis
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

EKF Diagnostics Holdings ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view EKF Diagnostics Holdings’s complete esg history, request access »

EKF Diagnostics Holdings Exits (5)

EKF Diagnostics Holdings’s most recent exit was on 07-Mar-2022 from Verici Dx. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Verici Dx 07-Mar-2022 Completed
  • 3 buyers
Advanced Diagnostic Laboratory 12-Oct-2021 Completed
Trellus (Other Healthcare Services) 20-Aug-2020 Completed
  • 2 buyers
Selah Genomics 17-Apr-2014 Completed
  • 2 buyers
DiaSpect Medical 21-Mar-2014 Merger/Acquisition Completed
To view EKF Diagnostics Holdings’s complete exits history, request access »

EKF Diagnostics Holdings Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Renalytix London, United Kingdom 2018
Quotient Diagnostics Surrey, United Kingdom 2003
EKF Diagnostics (point-of-care business) Cardiff, United Kingdom 2001
Ekf-Diagnostic Barleben, Germany 1990
Separation Technology Sanford, FL 1988

EKF Diagnostics Holdings FAQs

  • When was EKF Diagnostics Holdings founded?

    EKF Diagnostics Holdings was founded in 1990.

  • Where is EKF Diagnostics Holdings headquartered?

    EKF Diagnostics Holdings is headquartered in Cardiff, United Kingdom.

  • What is the size of EKF Diagnostics Holdings?

    EKF Diagnostics Holdings has 301 total employees.

  • What industry is EKF Diagnostics Holdings in?

    EKF Diagnostics Holdings’s primary industry is Diagnostic Equipment.

  • Is EKF Diagnostics Holdings a private or public company?

    EKF Diagnostics Holdings is a Public company.

  • What is EKF Diagnostics Holdings’s stock symbol?

    The ticker symbol for EKF Diagnostics Holdings is EKF.

  • What is the current stock price of EKF Diagnostics Holdings?

    As of 18-Nov-2026 the stock price of EKF Diagnostics Holdings is $0.31.

  • What is the current market cap of EKF Diagnostics Holdings?

    The current market capitalization of EKF Diagnostics Holdings is $132M.

  • What is EKF Diagnostics Holdings’s current revenue?

    The trailing twelve month revenue for EKF Diagnostics Holdings is $68.9M.

  • Who are EKF Diagnostics Holdings’s competitors?

    Orasure Technologies, Bio-Rad Laboratories, Abbott India, GE HealthCare Technologies, and Guerbet Group are competitors of EKF Diagnostics Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process